Home Page
Gifts & Grants
Fund Raising
Managing Nonprofit Groups
Technology
Philanthropy Today
Jobs
Guide to Grants
The Nonprofit Handbook
Facts & Figures
Events
Deadlines
Current Issue
Back Issues
Directory of Services
Guide to Managing Nonprofits
Continuing-Education Guide
Fund-Raising Services Guide
Technology Guide
About The Chronicle
How to Contact Us
How to Subscribe
How to Register
Manage Your Account
How to Advertise
Press Inquiries
Feedback
Privacy Policy
User Agreement
Help
|
|
|
|
|
|
September 25, 2008
Clinton Global Initiative
Gates Promises $168.7-Million For Malaria Vaccine
During a meeting at the United Nations today, Bill Gates said his foundation is awarding $168.7-million to create a malaria vaccine.
The money will support work by PATH, a large health nonprofit group in Seattle, to develop a potential anti-malaria drug with pharmaceutical giant GlaxoSmithKline.
“I’m very hopeful that the malaria vaccine currently in advanced testing will be proven effective, but that will just be the first step,” said Mr. Gates. “Now it’s time to develop a new generation of vaccines that are even more effective, and could someday help eradicate malaria altogether.”
The grant was announced as world leaders said they plan to eradicate malaria by 2015.
In addition to the Gates grant, other private contributions to anti-malaria work announced today include $1.6-billion from the Global Fund to Fight AIDS, Tuberculosis, and Malaria to pay for the distribution of bed nets; $2-million from the United Nations Foundation; and $28-million from Marathon Oil, in Houston, to increase malaria prevention projects in Equatorial Guinea.
Commenting is closed for this article.
Previous: Broad Promises $6-Million Education-Research Gift
Next: Clinton and the News Media
Copyright © 2008 The Chronicle of Philanthropy